An Exploratory Study of DS-8500a on Beta Cell Function Using Hyperglycemic Clamp
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate change in insulin secretory capacity in patients
with type 2 diabetes mellitus as determined by hyperglycemic clamp after a 28-day oral
administration of DS-8500a at 75 mg in a placebo-controlled, 2 × 2 crossover study. In
addition, safety of this regimen will be examined in this study.